NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.

Effective treatment of childhood obesity significantly lowers long-term health risks, including type 2 diabetes and ...

The American College of Clinical Pharmacology® (ACCP) is pleased to announce the establishment of the Pediatric & Maternal Clinical Pharmacology Community, the first initiative in its effort to unite ...

While the Centers for Disease Control and Prevention states that weight lifting is not necessary for children, it recommends ...

Developmental milestones are physical or behavioral signs of progress in infants and children. Unlike growth, these are ...

Many parents worry when their baby does not gain weight as expected; however, it is important to understand that the growth ...

virtual health service market size is projected to reach US$ 78.84 Bn by 2030 from an estimated US$ 11.11 Bn in 2023, exhibiting a CAGR of 32.3%.

"Throughout 2024 we continued to deliver strong results, advance our strategic initiatives, and grow our market share within pediatric orthopedics. Our Trauma and Deformity and Scoliosis businesses ...

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...

Governor Nandalal Weerasinghe indicated the commitment of the institution to inflation stabilisation at 5 per cent within its flexible inflation targeting framework and supported sustainable economic ...

Our chart shows that since 2000, if Ontario maintained the real per-capita growth rate of the 1980s and 1990s, that figure would be $90,603. In other words, the province would be 26.4-per-cent ...

Cast your eyes on the accompanying charts. Chart 1 shows the drivers of real GDP growth in FY25, according to the National Statistics Office’s first advance estimates. The chart shows that ...